Evidence map›Paper›PMID 30092773›Full record

ArticleBMC medical genetics2018

The altered activity of P53 signaling pathway by STK11 gene mutations and its cancer phenotype in Peutz-Jeghers syndrome.

Yu-Liang Jiang, Zi-Ye Zhao, Bai-Rong Li, Fu Yang, Jing Li, Xiao-Wei Jin, Hao Wang, En-Da Yu, Shu-Han Sun, Shou-Bin Ning

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Strategy for early diagnosis of pancreatic cancer.Frontiers in gastroenterology (Lausanne, Switzerland) · 2026
    Review
  2. Comprehensively Testing the Function of Missense Variation in thebioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yu-Liang JiangHebei North University, Zhangjiakou, 075061, Hebei Province, China.
Zi-Ye ZhaoDepartment of Medical Genetics, Naval Medical University, Shanghai, 200433, China.
Bai-Rong LiDepartment of Gastroenterology, Airforce General Hospital of PLA, Beijing, 100142, China.
Fu YangDepartment of Medical Genetics, Naval Medical University, Shanghai, 200433, China.
Jing LiDepartment of Gastroenterology, Airforce General Hospital of PLA, Beijing, 100142, China.
Xiao-Wei JinDepartment of Gastroenterology, Airforce General Hospital of PLA, Beijing, 100142, China.
Hao WangDepartment of Colorectal Surgery, Changhai Hospital, Shanghai, 200433, China.
En-Da YuDepartment of Colorectal Surgery, Changhai Hospital, Shanghai, 200433, China.
Shu-Han SunDepartment of Medical Genetics, Naval Medical University, Shanghai, 200433, China. shsun@vip.sina.com.
Shou-Bin NingDepartment of Gastroenterology, Airforce General Hospital of PLA, Beijing, 100142, China. ningshoubin@126.com.ORCID 0000-0001-7204-3956
Air Force General Hospital PLA · CNSecond Military Medical University · CNHebei North University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeutz-Jeghers syndrome (PJS) is caused by mutations in serine/threonine kinase 11 (STK11) gene. The increased cancer risk has been connected to P53 pathway.

methodsPJS probands with STK11 mutation were included in the function analysis. P53 activity elevated by STK11 mutants was investigated using dual-luciferase reporter assay in vitro after constructing expression vectors of STK11 wild type and mutants generated by site-directed substitution. The association between the P53 activity and clinicopathological factors was analysis, especially the cancer history.

resultsThirteen probands with STK11 mutations were involved, and within the mutations, c.G924A was novel. P53 activity elevation caused by 6 truncating mutations were significantly lower than that of STK11 wild type (P < 0.05). Family history of cancer was observed in 5 families. Within them, P53 activity was reduced and cancer occurred before 40 in 2 families, while it was not significantly changed and cancers happened after 45 in the other 3 families.

conclusionsThe affected P53 activity caused by STK11 mutations in PJS patients is significantly associated with protein truncation, while cancer risk in PJS can be elevated through pathways rather than P53 pathway. P53 activity test is probably a useful supporting method to predict cancer risk in PJS, which could be helpful in clinical practice.

Indexed as

AdolescentAdultAMP-Activated Protein Kinase KinasesChildFemaleHumansMaleMiddle AgedMutationNeoplasmsPeutz-Jeghers SyndromePhenotypeProtein Serine-Threonine KinasesSignal TransductionTumor Suppressor Protein p53Young AdultAMP-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesSTK11 protein, humanTP53 protein, humanTumor Suppressor Protein p53Cancer riskP53 genePeutz-Jeghers syndrome (PJS)Reporter gene techniqueSTK11 gene

Identifiers

PMID30092773
PMCPMC6085611
OpenAlexW2886906805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.